Abbott raises annual profit forecast as strong medical device sales power quarterly beat
The company now expects a profit of US$4.61 to US$4.71 per share for the full yearABBOTT Laboratories raised its annual ...
The company now expects a profit of US$4.61 to US$4.71 per share for the full yearABBOTT Laboratories raised its annual ...
ABBOTT Laboratories said on Monday (Jun 11) the US health regulator had cleared the company’s two new over-the-counter glucose monitoring ...
Indian drugmaker Abbott India reported a 24 per cent rise in fourth-quarter profit on Thursday (May 9), as strong sales ...
ABBOTT Laboratories beat Wall Street estimates for quarterly profit on Wednesday (Apr 17) and raised the lower end of its ...
Forbes 40under40 stands as a distinguished platform revered for its commitment to honoring and applauding the remarkable achievements of exceptional individuals who have yet to reach the age of 40. This esteemed initiative serves as a beacon of inspiration, spotlighting trailblazers across various industries and domains, showcasing their innovation, leadership, and impact on a global scale.
© 2024 Forbes 40under40. All Rights Reserved.